Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rouba Ali-Fehmi

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
Annals of Nuclear Medicine|February 28, 2019
The use of 3'-deoxy-3'-<sup>18</sup>F-fluorothymidine (FLT) PET in the assessment of long-term survival in breast cancer patients treated with neoadjuvant chemotherapyBenjamin E Ueberroth, Jawana M Lawhorn-Crews, Lance K Heilbrun, et al.
Gynecologic Oncology|December 17, 2014
Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution studyMohamed A Elshaikh, Zaid Al-Wahab, Haider Mahdi, et al.
Journal of Neuro-Oncology|April 19, 2018
Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumorsAnthony R Guastella, Sharon K Michelhaugh, Neil V Klinger, et al.
Oncotarget|April 21, 2015
Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restrictionZaid Al-Wahab, Ismail Mert, Calvin Tebbe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 26, 2017
Clear Cell Carcinoma of the Endometrium: Evaluation of Prognostic Parameters in a Multi-institutional Cohort of 165 CasesEman Abdulfatah, Sharif Sakr, Sumi Thomas, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 26, 2012
Outcomes of patients with uterine serous carcinoma using the revised FIGO staging systemShelly Seward, Rouba Ali-Fehmi, Adnan R Munkarah, et al.
Breast Cancer Research and Treatment|October 28, 2020
Inflammation markers on benign breast biopsy are associated with risk of invasive breast cancer in African American womenAsra N Shaik, Katrin Kiavash, Karri Stark, et al.
Gynecologic Oncology|March 8, 2011
The impact of race on survival in uterine serous carcinoma: a hospital-based studyZaid Al-Wahab, Rouba Ali-Fehmi, Michele L Cote, et al.
Cancer|September 7, 2010
Molecular typing of epithelial ovarian carcinomas using inflammatory markersRouba Ali-Fehmi, Assaad Semaan, Sima Sethi, et al.
Human Pathology|March 23, 2012
Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancerYaser R Hussein, Anil K Sood, Sudeshna Bandyopadhyay, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Annals of Nuclear Medicine|February 28, 2019
The use of 3'-deoxy-3'-<sup>18</sup>F-fluorothymidine (FLT) PET in the assessment of long-term survival in breast cancer patients treated with neoadjuvant chemotherapyBenjamin E Ueberroth, Jawana M Lawhorn-Crews, Lance K Heilbrun, et al.
Gynecologic Oncology|December 17, 2014
Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution studyMohamed A Elshaikh, Zaid Al-Wahab, Haider Mahdi, et al.
Journal of Neuro-Oncology|April 19, 2018
Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumorsAnthony R Guastella, Sharon K Michelhaugh, Neil V Klinger, et al.
Oncotarget|April 21, 2015
Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restrictionZaid Al-Wahab, Ismail Mert, Calvin Tebbe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 26, 2017
Clear Cell Carcinoma of the Endometrium: Evaluation of Prognostic Parameters in a Multi-institutional Cohort of 165 CasesEman Abdulfatah, Sharif Sakr, Sumi Thomas, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 26, 2012
Outcomes of patients with uterine serous carcinoma using the revised FIGO staging systemShelly Seward, Rouba Ali-Fehmi, Adnan R Munkarah, et al.
Breast Cancer Research and Treatment|October 28, 2020
Inflammation markers on benign breast biopsy are associated with risk of invasive breast cancer in African American womenAsra N Shaik, Katrin Kiavash, Karri Stark, et al.
Gynecologic Oncology|March 8, 2011
The impact of race on survival in uterine serous carcinoma: a hospital-based studyZaid Al-Wahab, Rouba Ali-Fehmi, Michele L Cote, et al.
Cancer|September 7, 2010
Molecular typing of epithelial ovarian carcinomas using inflammatory markersRouba Ali-Fehmi, Assaad Semaan, Sima Sethi, et al.
Human Pathology|March 23, 2012
Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancerYaser R Hussein, Anil K Sood, Sudeshna Bandyopadhyay, et al.
Pageof 15